All Pharma News
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study

Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
Ned Pagliarulo BIOPHARMADIVE
19 Apr 2024
Share Share
Cerevel`s Tavapadon Meets Phase 3 Adjunctive Parkinson`s Trial Goals

Cerevel`s Tavapadon Meets Phase 3 Adjunctive Parkinson`s Trial Goals
GLOBENEWSWIRE
18 Apr 2024
Share Share
Cerevel Therapeutics is lower by 3.66% Tuesday In Premarket Trading

Cerevel Therapeutics is lower by 3.66% Tuesday In Premarket Trading
INVESTOR OBSERVER
01 Feb 2024
Share Share
AbbVie to acquire Cerevel for $8.7 billion

AbbVie to acquire Cerevel for $8.7 billion
Ananya M. Rajesh REUTERS
07 Dec 2023
Share Share
Cerevel to Host Investor Webcast on Tavapadon in Parkinson™s Disease

Cerevel to Host Investor Webcast on Tavapadon in Parkinson™s Disease
GLOBENEWSWIRE
29 Nov 2023
Share Share
Cerevel to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference

Cerevel to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
PRESS RELEASE
23 Nov 2023
Share Share
Cerevel Therapeutics Announces Third Quarter 2020 Financial Results

Cerevel Therapeutics Announces Third Quarter 2020 Financial Results
PRESS RELEASE
16 Nov 2023
Share Share
Cerevel Therapeutics to Present at Upcoming Investor Conferences

Cerevel Therapeutics to Present at Upcoming Investor Conferences
GLOBENEWSWIRE
08 Nov 2023
Share Share
Cerevel Reports Third Quarter 2023 Financial Results and Business Updates

Cerevel Reports Third Quarter 2023 Financial Results and Business Updates
GLOBENEWSWIRE
01 Nov 2023
Share Share
Cerevel Therapeutics to Report Third Quarter 2023 Financial Results

Cerevel Therapeutics to Report Third Quarter 2023 Financial Results
GLOBENEWSWIRE
13 Oct 2023
Share Share